{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:18:55Z","timestamp":1792451935954,"version":"4.5.0"},"reference-count":160,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20H04129"],"award-info":[{"award-number":["JP20H04129"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["21fk0210096h0001"],"award-info":[{"award-number":["21fk0210096h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm Regener"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The liver presents a unique immune system. Liver diseases are closely associated with the immune system. Disruption of the tightly regulated balance between immune activation and tolerance induction leads to the development and worsening of immune-related liver diseases. T cells play diverse crucial roles in the immune system, and they have long been known to induce inflammation through direct tissue damage by effector molecules and the recruitment of effector cells via chemokines. Additionally, T cells interact with B cells to induce autoantibodies, promoting tissue inflammation and dysfunction through the deposition of IgG and immune complexes in the tissues. Recent advances in omics technologies, including single-cell RNA sequencing and spatial transcriptomics, have elucidated the role of T cells in the progression and recovery of liver fibrosis. Moreover, comprehensive and unbiased information can now be obtained from small samples of human and mouse tissues, which advances our understanding of tissue-specific functions of T cells, including resident memory T cells, peripheral helper T cells, and tissue Tregs. However, significant unmet needs remain in the fields of immune-related liver diseases. In this review, we discuss the T cell biology and its role in autoimmune hepatitis (AIH), primary sclerosing cholangitis (PSC), primary biliary cholangitis (PBC), and metabolic-associated steatohepatitis (MASH), which are non-viral liver diseases exhibiting a strong involvement of immunity and inflammation. Furthermore, the latest therapeutic concepts for the diseases and associated drugs targeting T cells have been overviewed.<\/jats:p>","DOI":"10.1186\/s41232-025-00387-0","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T10:29:46Z","timestamp":1751624986000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The impact of T cells on immune-related liver diseases: an overview"],"prefix":"10.1186","volume":"45","author":[{"given":"Yuzo","family":"Koda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Kasuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhito","family":"Taniki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5203-7444","authenticated-orcid":false,"given":"Nobuhiro","family":"Nakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"issue":"1","key":"387_CR1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nri981","volume":"3","author":"IN Crispe","year":"2003","unstructured":"Crispe IN. Hepatic T cells and liver tolerance. Nat Rev Immunol. 2003;3(1):51\u201362.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"387_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0030113","volume":"3","author":"F Geissmann","year":"2005","unstructured":"Geissmann F, Cameron TO, Sidobre S, Manlongat N, Kronenberg M, Briskin MJ, et al. Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol. 2005;3(4): e113.","journal-title":"PLoS Biol"},{"issue":"8013","key":"387_CR3","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/s41586-024-07372-6","volume":"629","author":"Y Miyamoto","year":"2024","unstructured":"Miyamoto Y, Kikuta J, Matsui T, Hasegawa T, Fujii K, Okuzaki D, et al. Periportal macrophages protect against commensal-driven liver inflammation. Nature. 2024;629(8013):901\u20139.","journal-title":"Nature"},{"issue":"10","key":"387_CR4","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","volume":"20","author":"L Hammerich","year":"2023","unstructured":"Hammerich L, Tacke F. Hepatic inflammatory responses in liver fibrosis. Nat Rev Gastroenterol Hepatol. 2023;20(10):633\u201346.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"387_CR5","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.3389\/fimmu.2019.01582","volume":"10","author":"Y Wang","year":"2019","unstructured":"Wang Y, Zhang C. The roles of liver-resident lymphocytes in liver diseases. Front Immunol. 2019;10:1582.","journal-title":"Front Immunol"},{"issue":"1","key":"387_CR6","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1038\/s41467-021-24734-0","volume":"12","author":"Y Koda","year":"2021","unstructured":"Koda Y, Teratani T, Chu PS, Hagihara Y, Mikami Y, Harada Y, et al. CD8(+) tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells. Nat Commun. 2021;12(1):4474.","journal-title":"Nat Commun"},{"issue":"12","key":"387_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202250218","volume":"53","author":"CE Zielinski","year":"2023","unstructured":"Zielinski CE. T helper cell subsets: diversification of the field. Eur J Immunol. 2023;53(12): e2250218.","journal-title":"Eur J Immunol"},{"issue":"11","key":"387_CR8","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1136\/ard-2023-224225","volume":"82","author":"M Akiyama","year":"2023","unstructured":"Akiyama M, Alshehri W, Yoshimoto K, Kaneko Y. T follicular helper cells and T peripheral helper cells in rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2023;82(11):1371\u201381.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"387_CR9","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41423-020-00529-z","volume":"18","author":"H Yoshitomi","year":"2021","unstructured":"Yoshitomi H, Ueno H. Shared and distinct roles of T peripheral helper and T follicular helper cells in human diseases. Cell Mol Immunol. 2021;18(3):523\u20137.","journal-title":"Cell Mol Immunol"},{"issue":"7639","key":"387_CR10","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature20810","volume":"542","author":"DA Rao","year":"2017","unstructured":"Rao DA, Gurish MF, Marshall JL, Slowikowski K, Fonseka CY, Liu Y, et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature. 2017;542(7639):110\u20134.","journal-title":"Nature"},{"issue":"4","key":"387_CR11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00281-022-00917-9","volume":"44","author":"N Taniki","year":"2022","unstructured":"Taniki N, Nakamoto N, Chu PS, Ichikawa M, Teratani T, Kanai T. Th17 cells in the liver: balancing autoimmunity and pathogen defense. Semin Immunopathol. 2022;44(4):509\u201326.","journal-title":"Semin Immunopathol"},{"issue":"4","key":"387_CR12","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1055\/a-1957-6384","volume":"42","author":"Y Koda","year":"2022","unstructured":"Koda Y, Nakamoto N, Kanai T. Regulation of progression and resolution of liver fibrosis by immune cells. Semin Liver Dis. 2022;42(4):475\u201388.","journal-title":"Semin Liver Dis"},{"issue":"5","key":"387_CR13","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1002\/hep.21823","volume":"46","author":"X Ma","year":"2007","unstructured":"Ma X, Hua J, Mohamood AR, Hamad AR, Ravi R, Li Z. A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury. Hepatology. 2007;46(5):1519\u201329.","journal-title":"Hepatology"},{"issue":"3","key":"387_CR14","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41564-018-0333-1","volume":"4","author":"N Nakamoto","year":"2019","unstructured":"Nakamoto N, Sasaki N, Aoki R, Miyamoto K, Suda W, Teratani T, et al. Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis. Nat Microbiol. 2019;4(3):492\u2013503.","journal-title":"Nat Microbiol"},{"issue":"3","key":"387_CR15","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00125-020-05349-4","volume":"64","author":"T Amiya","year":"2021","unstructured":"Amiya T, Nakamoto N, Irie J, Taniki N, Chu PS, Koda Y, et al. C-C motif chemokine receptor 9 regulates obesity-induced insulin resistance via inflammation of the small intestine in mice. Diabetologia. 2021;64(3):603\u201317.","journal-title":"Diabetologia"},{"issue":"7593","key":"387_CR16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nature16969","volume":"531","author":"C Ma","year":"2016","unstructured":"Ma C, Kesarwala AH, Eggert T, Medina-Echeverz J, Kleiner DE, Jin P, et al. NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis. Nature. 2016;531(7593):253\u20137.","journal-title":"Nature"},{"issue":"4","key":"387_CR17","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1002\/hep.31140","volume":"72","author":"LK Kunzmann","year":"2020","unstructured":"Kunzmann LK, Schoknecht T, Poch T, Henze L, Stein S, Kriz M, et al. Monocytes as potential mediators of pathogen-induced T-helper 17 differentiation in patients with primary sclerosing cholangitis (PSC). Hepatology. 2020;72(4):1310\u201326.","journal-title":"Hepatology"},{"key":"387_CR18","doi-asserted-by":"crossref","unstructured":"Zimmer CL, von Seth E, Buggert M, Strauss O, Hertwig L, Nguyen S, et al. A biliary immune landscape map of primary sclerosing cholangitis reveals a dominant network of neutrophils and tissue-resident T cells. Sci Transl Med. 2021;13(599).","DOI":"10.1126\/scitranslmed.abb3107"},{"key":"387_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.661196","volume":"12","author":"T Cargill","year":"2021","unstructured":"Cargill T, Culver EL. The Role of B Cells and B Cell Therapies in Immune-Mediated Liver Diseases. Front Immunol. 2021;12: 661196.","journal-title":"Front Immunol"},{"issue":"6","key":"387_CR20","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/hep.27725","volume":"61","author":"Y Li","year":"2015","unstructured":"Li Y, Wang W, Tang L, He X, Yan X, Zhang X, et al. Chemokine (C-X-C motif) ligand 13 promotes intrahepatic chemokine (C-X-C motif) receptor 5+ lymphocyte homing and aberrant B-cell immune responses in primary biliary cirrhosis. Hepatology. 2015;61(6):1998\u20132007.","journal-title":"Hepatology"},{"issue":"11","key":"387_CR21","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1038\/s12276-023-01105-x","volume":"55","author":"CH Koh","year":"2023","unstructured":"Koh CH, Lee S, Kwak M, Kim BS, Chung Y. CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential. Exp Mol Med. 2023;55(11):2287\u201399.","journal-title":"Exp Mol Med"},{"issue":"6","key":"387_CR22","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00005-014-0293-y","volume":"62","author":"HW Mittrucker","year":"2014","unstructured":"Mittrucker HW, Visekruna A, Huber M. Heterogeneity in the differentiation and function of CD8(+) T cells. Arch Immunol Ther Exp (Warsz). 2014;62(6):449\u201358.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"4","key":"387_CR23","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ccell.2014.09.003","volume":"26","author":"MJ Wolf","year":"2014","unstructured":"Wolf MJ, Adili A, Piotrowitz K, Abdullah Z, Boege Y, Stemmer K, et al. Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. Cancer Cell. 2014;26(4):549\u201364.","journal-title":"Cancer Cell"},{"issue":"4","key":"387_CR24","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/hep4.1041","volume":"1","author":"J Bhattacharjee","year":"2017","unstructured":"Bhattacharjee J, Kirby M, Softic S, Miles L, Salazar-Gonzalez RM, Shivakumar P, et al. Hepatic natural killer T-cell and CD8+ T-cell signatures in mice with nonalcoholic steatohepatitis. Hepatol Commun. 2017;1(4):299\u2013310.","journal-title":"Hepatol Commun"},{"issue":"7854","key":"387_CR25","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-021-03233-8","volume":"592","author":"M Dudek","year":"2021","unstructured":"Dudek M, Pfister D, Donakonda S, Filpe P, Schneider A, Laschinger M, et al. Auto-aggressive CXCR6(+) CD8 T cells cause liver immune pathology in NASH. Nature. 2021;592(7854):444\u20139.","journal-title":"Nature"},{"issue":"3","key":"387_CR26","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1053\/j.gastro.2004.04.062","volume":"127","author":"R Safadi","year":"2004","unstructured":"Safadi R, Ohta M, Alvarez CE, Fiel MI, Bansal M, Mehal WZ, et al. Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes. Gastroenterology. 2004;127(3):870\u201382.","journal-title":"Gastroenterology"},{"issue":"5","key":"387_CR27","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/hep.30061","volume":"68","author":"AE Taylor","year":"2018","unstructured":"Taylor AE, Carey AN, Kudira R, Lages CS, Shi T, Lam S, et al. Interleukin 2 promotes hepatic regulatory T cell responses and protects from biliary fibrosis in murine sclerosing cholangitis. Hepatology. 2018;68(5):1905\u201321.","journal-title":"Hepatology"},{"issue":"6","key":"387_CR28","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1203\/01.PDR.0000161414.99181.61","volume":"57","author":"PF Whitington","year":"2005","unstructured":"Whitington PF, Malladi P, Melin-Aldana H, Azzam R, Mack CL, Sahai A. Expression of osteopontin correlates with portal biliary proliferation and fibrosis in biliary atresia. Pediatr Res. 2005;57(6):837\u201344.","journal-title":"Pediatr Res"},{"issue":"4","key":"387_CR29","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jhep.2019.05.023","volume":"71","author":"G Ravichandran","year":"2019","unstructured":"Ravichandran G, Neumann K, Berkhout LK, Weidemann S, Langeneckert AE, Schwinge D, et al. Interferon-gamma-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice. J Hepatol. 2019;71(4):773\u201382.","journal-title":"J Hepatol"},{"issue":"7","key":"387_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100757","volume":"5","author":"S Fujimori","year":"2023","unstructured":"Fujimori S, Chu PS, Teratani T, Harada Y, Suzuki T, Amiya T, et al. IL-15-producing splenic B cells play pathogenic roles in the development of autoimmune hepatitis. JHEP Rep. 2023;5(7): 100757.","journal-title":"JHEP Rep"},{"issue":"7","key":"387_CR31","doi-asserted-by":"publisher","first-page":"8490","DOI":"10.1096\/fj.201802534RR","volume":"33","author":"T Wang","year":"2019","unstructured":"Wang T, Sun G, Wang Y, Li S, Zhao X, Zhang C, et al. The immunoregulatory effects of CD8 T-cell-derived perforin on diet-induced nonalcoholic steatohepatitis. FASEB J. 2019;33(7):8490\u2013503.","journal-title":"FASEB J"},{"issue":"1","key":"387_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s41232-024-00333-6","volume":"44","author":"M Murakami","year":"2024","unstructured":"Murakami M. Tissue-resident memory T cells: decoding intra-organ diversity with a gut perspective. Inflamm Regen. 2024;44(1):19.","journal-title":"Inflamm Regen"},{"key":"387_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.967055","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y, You Z, Tang R, Ma X. Tissue-resident memory T cells in chronic liver diseases: phenotype, development and function. Front Immunol. 2022;13: 967055.","journal-title":"Front Immunol"},{"issue":"7","key":"387_CR34","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/s41590-023-01538-6","volume":"24","author":"M Buggert","year":"2023","unstructured":"Buggert M, Price DA, Mackay LK, Betts MR. Human circulating and tissue-resident memory CD8(+) T cells. Nat Immunol. 2023;24(7):1076\u201386.","journal-title":"Nat Immunol"},{"issue":"6","key":"387_CR35","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1084\/jem.20162115","volume":"214","author":"LJ Pallett","year":"2017","unstructured":"Pallett LJ, Davies J, Colbeck EJ, Robertson F, Hansi N, Easom NJW, et al. IL-2(high) tissue-resident T cells in the human liver: sentinels for hepatotropic infection. J Exp Med. 2017;214(6):1567\u201380.","journal-title":"J Exp Med"},{"key":"387_CR36","doi-asserted-by":"crossref","unstructured":"Obers A, Poch T, Rodrigues G, Christo SN, Gandolfo LC, Fonseca R, et al. Retinoic acid and TGF-beta orchestrate organ-specific programs of tissue residency. Immunity. 2024;57(11):2615\u201333 e10.","DOI":"10.1016\/j.immuni.2024.09.015"},{"issue":"6","key":"387_CR37","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1084\/jem.20170842","volume":"214","author":"FJ Bolte","year":"2017","unstructured":"Bolte FJ, Rehermann B. Tissue-resident T cells in hepatitis B: A new target for cure? J Exp Med. 2017;214(6):1564\u20136.","journal-title":"J Exp Med"},{"key":"387_CR38","doi-asserted-by":"crossref","unstructured":"Holz LE, Chua YC, de Menezes MN, Anderson RJ, Draper SL, Compton BJ, et al. Glycolipid-peptide vaccination induces liver-resident memory CD8(+) T cells that protect against rodent malaria. Sci Immunol. 2020;5(48).","DOI":"10.4049\/jimmunol.204.Supp.168.1"},{"issue":"1","key":"387_CR39","doi-asserted-by":"publisher","first-page":"6172","DOI":"10.1038\/s41598-017-06352-3","volume":"7","author":"F Stelma","year":"2017","unstructured":"Stelma F, de Niet A, Sinnige MJ, van Dort KA, van Gisbergen K, Verheij J, et al. Human intrahepatic CD69 + CD8+ T cells have a tissue resident memory T cell phenotype with reduced cytolytic capacity. Sci Rep. 2017;7(1):6172.","journal-title":"Sci Rep"},{"issue":"1","key":"387_CR40","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1038\/s41467-024-46654-5","volume":"15","author":"HX Zhu","year":"2024","unstructured":"Zhu HX, Yang SH, Gao CY, Bian ZH, Chen XM, Huang RR, et al. Targeting pathogenic CD8(+) tissue-resident T cells with chimeric antigen receptor therapy in murine autoimmune cholangitis. Nat Commun. 2024;15(1):2936.","journal-title":"Nat Commun"},{"issue":"2","key":"387_CR41","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/hep.31739","volume":"74","author":"Z You","year":"2021","unstructured":"You Z, Li Y, Wang Q, Zhao Z, Li Y, Qian Q, et al. The clinical significance of hepatic CD69(+) CD103(+) CD8(+) resident-memory T cells in autoimmune hepatitis. Hepatology. 2021;74(2):847\u201363.","journal-title":"Hepatology"},{"issue":"1","key":"387_CR42","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.smim.2008.09.002","volume":"21","author":"M Iwata","year":"2009","unstructured":"Iwata M. Retinoic acid production by intestinal dendritic cells and its role in T-cell trafficking. Semin Immunol. 2009;21(1):8\u201313.","journal-title":"Semin Immunol"},{"issue":"11","key":"387_CR43","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1084\/jem.20041035","volume":"200","author":"B Eksteen","year":"2004","unstructured":"Eksteen B, Grant AJ, Miles A, Curbishley SM, Lalor PF, Hubscher SG, et al. Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis. J Exp Med. 2004;200(11):1511\u20137.","journal-title":"J Exp Med"},{"issue":"9","key":"387_CR44","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1002\/hep4.2001","volume":"6","author":"BK Chung","year":"2022","unstructured":"Chung BK, Ogaard J, Reims HM, Karlsen TH, Melum E. Spatial transcriptomics identifies enriched gene expression and cell types in human liver fibrosis. Hepatol Commun. 2022;6(9):2538\u201350.","journal-title":"Hepatol Commun"},{"issue":"8054","key":"387_CR45","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/s41586-024-08466-x","volume":"639","author":"M Reina-Campos","year":"2025","unstructured":"Reina-Campos M, Monell A, Ferry A, Luna V, Cheung KP, Galletti G, et al. Tissue-resident memory CD8 T cell diversity is spatiotemporally imprinted. Nature. 2025;639(8054):483\u201392.","journal-title":"Nature"},{"key":"387_CR46","doi-asserted-by":"crossref","unstructured":"Marra F, Tacke F. Roles for chemokines in liver disease. Gastroenterology. 2014;147(3):577\u201394 e1.","DOI":"10.1053\/j.gastro.2014.06.043"},{"issue":"9","key":"387_CR47","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1093\/infdis\/jiu281","volume":"210","author":"SW Tse","year":"2014","unstructured":"Tse SW, Radtke AJ, Espinosa DA, Cockburn IA, Zavala F. The chemokine receptor CXCR6 is required for the maintenance of liver memory CD8(+) T cells specific for infectious pathogens. J Infect Dis. 2014;210(9):1508\u201316.","journal-title":"J Infect Dis"},{"issue":"3","key":"387_CR48","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00281-009-0167-2","volume":"31","author":"AT Borchers","year":"2009","unstructured":"Borchers AT, Shimoda S, Bowlus C, Keen CL, Gershwin ME. Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis. Semin Immunopathol. 2009;31(3):309\u201322.","journal-title":"Semin Immunopathol"},{"key":"387_CR49","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.molimm.2020.09.007","volume":"131","author":"L Yong","year":"2021","unstructured":"Yong L, Chunyan W, Yan Y, Wanyu L, Huifan J, Pingwei Z, et al. Expanded circulating peripheral helper T cells in primary biliary cholangitis: Tph cells in PBC. Mol Immunol. 2021;131:44\u201350.","journal-title":"Mol Immunol"},{"issue":"2","key":"387_CR50","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.4049\/jimmunol.174.2.1055","volume":"174","author":"M Heydtmann","year":"2005","unstructured":"Heydtmann M, Lalor PF, Eksteen JA, Hubscher SG, Briskin M, Adams DH. CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver. J Immunol. 2005;174(2):1055\u201362.","journal-title":"J Immunol"},{"issue":"7083","key":"387_CR51","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nature04606","volume":"440","author":"LR Shiow","year":"2006","unstructured":"Shiow LR, Rosen DB, Brdickova N, Xu Y, An J, Lanier LL, et al. CD69 acts downstream of interferon-alpha\/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature. 2006;440(7083):540\u20134.","journal-title":"Nature"},{"issue":"5","key":"387_CR52","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.4049\/jimmunol.1402256","volume":"194","author":"LK Mackay","year":"2015","unstructured":"Mackay LK, Braun A, Macleod BL, Collins N, Tebartz C, Bedoui S, et al. Cutting edge: CD69 interference with sphingosine-1-phosphate receptor function regulates peripheral T cell retention. J Immunol. 2015;194(5):2059\u201363.","journal-title":"J Immunol"},{"issue":"10","key":"387_CR53","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1084\/jem.20041044","volume":"201","author":"R El-Asady","year":"2005","unstructured":"El-Asady R, Yuan R, Liu K, Wang D, Gress RE, Lucas PJ, et al. TGF-beta-dependent CD103 expression by CD8(+) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease. J Exp Med. 2005;201(10):1647\u201357.","journal-title":"J Exp Med"},{"issue":"6","key":"387_CR54","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.jhep.2022.08.018","volume":"77","author":"NK Bjorkstrom","year":"2022","unstructured":"Bjorkstrom NK. Immunobiology of the biliary tract system. J Hepatol. 2022;77(6):1657\u201369.","journal-title":"J Hepatol"},{"issue":"7","key":"387_CR55","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/nm1605","volume":"13","author":"C Conrad","year":"2007","unstructured":"Conrad C, Boyman O, Tonel G, Tun-Kyi A, Laggner U, de Fougerolles A, et al. Alpha1beta1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis. Nat Med. 2007;13(7):836\u201342.","journal-title":"Nat Med"},{"key":"387_CR56","doi-asserted-by":"crossref","unstructured":"McNamara HA, Cai Y, Wagle MV, Sontani Y, Roots CM, Miosge LA, et al. Up-regulation of LFA-1 allows liver-resident memory T cells to patrol and remain in the hepatic sinusoids. Sci Immunol. 2017;2(9).","DOI":"10.1126\/sciimmunol.aaj1996"},{"key":"387_CR57","doi-asserted-by":"publisher","first-page":"30","DOI":"10.12703\/r\/10-30","volume":"10","author":"MJ Butcher","year":"2021","unstructured":"Butcher MJ, Zhu J. Recent advances in understanding the Th1\/Th2 effector choice. Fac Rev. 2021;10:30.","journal-title":"Fac Rev"},{"issue":"1","key":"387_CR58","doi-asserted-by":"publisher","first-page":"294","DOI":"10.4049\/jimmunol.174.1.294","volume":"174","author":"ME Persky","year":"2005","unstructured":"Persky ME, Murphy KM, Farrar JD. IL-12, but not IFN-alpha, promotes STAT4 activation and Th1 development in murine CD4+ T cells expressing a chimeric murine\/human Stat2 gene. J Immunol. 2005;174(1):294\u2013301.","journal-title":"J Immunol"},{"issue":"8","key":"387_CR59","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1172\/JCI125863","volume":"129","author":"Y Koda","year":"2019","unstructured":"Koda Y, Nakamoto N, Chu PS, Ugamura A, Mikami Y, Teratani T, et al. Plasmacytoid dendritic cells protect against immune-mediated acute liver injury via IL-35. J Clin Invest. 2019;129(8):3201\u201313.","journal-title":"J Clin Invest"},{"key":"387_CR60","doi-asserted-by":"crossref","unstructured":"Koda Y, Nakamoto N, Chu PS, Teratani T, Ueno A, Amiya T, et al. CCR9 axis inhibition enhances hepatic migration of plasmacytoid DCs and protects against liver injury. JCI Insight. 2022;7(17).","DOI":"10.1172\/jci.insight.159910"},{"key":"387_CR61","doi-asserted-by":"crossref","unstructured":"Schlaak JF, Lohr H, Gallati H, Meyer zum Buschenfelde KH, Fleischer B. Analysis of the in vitro cytokine production by liver-infiltrating T cells of patients with autoimmune hepatitis. Clin Exp Immunol. 1993;94(1):168\u201373.","DOI":"10.1111\/j.1365-2249.1993.tb05996.x"},{"issue":"1","key":"387_CR62","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4049\/jimmunol.1501175","volume":"196","author":"M Rau","year":"2016","unstructured":"Rau M, Schilling AK, Meertens J, Hering I, Weiss J, Jurowich C, et al. Progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis is marked by a higher frequency of Th17 cells in the liver and an increased Th17\/resting regulatory T cell ratio in peripheral blood and in the liver. J Immunol. 2016;196(1):97\u2013105.","journal-title":"J Immunol"},{"issue":"1","key":"387_CR63","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ccell.2016.05.020","volume":"30","author":"AL Gomes","year":"2016","unstructured":"Gomes AL, Teijeiro A, Buren S, Tummala KS, Yilmaz M, Waisman A, et al. Metabolic inflammation-associated IL-17A causes non-alcoholic steatohepatitis and hepatocellular carcinoma. Cancer Cell. 2016;30(1):161\u201375.","journal-title":"Cancer Cell"},{"issue":"11","key":"387_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143380","volume":"10","author":"L Vonghia","year":"2015","unstructured":"Vonghia L, Magrone T, Verrijken A, Michielsen P, Van Gaal L, Jirillo E, et al. Peripheral and hepatic vein cytokine levels in correlation with non-alcoholic fatty liver disease (NAFLD)-Related metabolic, histological, and haemodynamic features. PLoS ONE. 2015;10(11): e0143380.","journal-title":"PLoS ONE"},{"issue":"3","key":"387_CR65","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1042\/CS20150405","volume":"130","author":"S Rolla","year":"2016","unstructured":"Rolla S, Alchera E, Imarisio C, Bardina V, Valente G, Cappello P, et al. The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice. Clin Sci (Lond). 2016;130(3):193\u2013203.","journal-title":"Clin Sci (Lond)"},{"key":"387_CR66","doi-asserted-by":"publisher","first-page":"175628482095925","DOI":"10.1177\/1756284820959252","volume":"13","author":"F Ditrich","year":"2020","unstructured":"Ditrich F, Blumel S, Biedermann L, Fournier N, Rossel JB, Ellinghaus D, et al. Genetic risk factors predict disease progression in Crohn\u2019s disease patients of the Swiss inflammatory bowel disease cohort. Therap Adv Gastroenterol. 2020;13:1756284820959252.","journal-title":"Therap Adv Gastroenterol"},{"issue":"1","key":"387_CR67","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/hep.28359","volume":"64","author":"GM Hirschfield","year":"2016","unstructured":"Hirschfield GM, Gershwin ME, Strauss R, Mayo MJ, Levy C, Zou B, et al. Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof-of-concept study. Hepatology. 2016;64(1):189\u201399.","journal-title":"Hepatology"},{"key":"387_CR68","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cytogfr.2018.07.002","volume":"42","author":"Y Mikami","year":"2018","unstructured":"Mikami Y, Takada Y, Hagihara Y, Kanai T. Innate lymphoid cells in organ fibrosis. Cytokine Growth Factor Rev. 2018;42:27\u201336.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"387_CR69","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.immuni.2013.07.018","volume":"39","author":"T McHedlidze","year":"2013","unstructured":"McHedlidze T, Waldner M, Zopf S, Walker J, Rankin AL, Schuchmann M, et al. Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis. Immunity. 2013;39(2):357\u201371.","journal-title":"Immunity"},{"key":"387_CR70","doi-asserted-by":"crossref","unstructured":"Li D, Guabiraba R, Besnard AG, Komai-Koma M, Jabir MS, Zhang L, et al. IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice. J Allergy Clin Immunol. 2014;134(6):1422\u201332 e11.","DOI":"10.1016\/j.jaci.2014.05.011"},{"key":"387_CR71","doi-asserted-by":"crossref","unstructured":"Hart KM, Fabre T, Sciurba JC, Gieseck RL, 3rd, Borthwick LA, Vannella KM, et al. Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-beta. Sci Transl Med. 2017;9(396).","DOI":"10.1126\/scitranslmed.aal3694"},{"issue":"1","key":"387_CR72","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/mi.2015.56","volume":"9","author":"D Karo-Atar","year":"2016","unstructured":"Karo-Atar D, Bordowitz A, Wand O, Pasmanik-Chor M, Fernandez IE, Itan M, et al. A protective role for IL-13 receptor alpha 1 in bleomycin-induced pulmonary injury and repair. Mucosal Immunol. 2016;9(1):240\u201353.","journal-title":"Mucosal Immunol"},{"issue":"6","key":"387_CR73","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1084\/jem.194.6.809","volume":"194","author":"CG Lee","year":"2001","unstructured":"Lee CG, Homer RJ, Zhu Z, Lanone S, Wang X, Koteliansky V, et al. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med. 2001;194(6):809\u201321.","journal-title":"J Exp Med"},{"key":"387_CR74","doi-asserted-by":"publisher","first-page":"1497095","DOI":"10.3389\/fimmu.2025.1497095","volume":"16","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Wang J, Li H, Niu Q, Tao Y, Zhao X, et al. The role of the interleukin family in liver fibrosis. Front Immunol. 2025;16:1497095.","journal-title":"Front Immunol"},{"key":"387_CR75","doi-asserted-by":"publisher","first-page":"18694","DOI":"10.1038\/srep18694","volume":"6","author":"SY Qin","year":"2016","unstructured":"Qin SY, Lu DH, Guo XY, Luo W, Hu BL, Huang XL, et al. A deleterious role for Th9\/IL-9 in hepatic fibrogenesis. Sci Rep. 2016;6:18694.","journal-title":"Sci Rep"},{"issue":"3","key":"387_CR76","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.immuni.2009.07.002","volume":"31","author":"D Yu","year":"2009","unstructured":"Yu D, Rao S, Tsai LM, Lee SK, He Y, Sutcliffe EL, et al. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity. 2009;31(3):457\u201368.","journal-title":"Immunity"},{"issue":"5943","key":"387_CR77","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1126\/science.1175870","volume":"325","author":"RJ Johnston","year":"2009","unstructured":"Johnston RJ, Poholek AC, DiToro D, Yusuf I, Eto D, Barnett B, et al. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science. 2009;325(5943):1006\u201310.","journal-title":"Science"},{"issue":"5943","key":"387_CR78","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1126\/science.1176676","volume":"325","author":"RI Nurieva","year":"2009","unstructured":"Nurieva RI, Chung Y, Martinez GJ, Yang XO, Tanaka S, Matskevitch TD, et al. Bcl6 mediates the development of T follicular helper cells. Science. 2009;325(5943):1001\u20135.","journal-title":"Science"},{"key":"387_CR79","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3389\/fimmu.2015.00296","volume":"6","author":"B Moser","year":"2015","unstructured":"Moser B. CXCR5, the defining marker for follicular B helper T (TFH) Cells. Front Immunol. 2015;6:296.","journal-title":"Front Immunol"},{"issue":"9","key":"387_CR80","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/ni.2947","volume":"15","author":"N Schmitt","year":"2014","unstructured":"Schmitt N, Liu Y, Bentebibel SE, Munagala I, Bourdery L, Venuprasad K, et al. The cytokine TGF-beta co-opts signaling via STAT3-STAT4 to promote the differentiation of human TFH cells. Nat Immunol. 2014;15(9):856\u201365.","journal-title":"Nat Immunol"},{"issue":"1","key":"387_CR81","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.immuni.2009.04.016","volume":"31","author":"N Schmitt","year":"2009","unstructured":"Schmitt N, Morita R, Bourdery L, Bentebibel SE, Zurawski SM, Banchereau J, et al. Human dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12. Immunity. 2009;31(1):158\u201369.","journal-title":"Immunity"},{"issue":"10","key":"387_CR82","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1093\/intimm\/dxac032","volume":"34","author":"S Tanemura","year":"2022","unstructured":"Tanemura S, Seki N, Tsujimoto H, Saito S, Kikuchi J, Sugahara K, et al. Role of interferons (IFNs) in the differentiation of T peripheral helper (Tph) cells. Int Immunol. 2022;34(10):533\u201344.","journal-title":"Int Immunol"},{"issue":"10","key":"387_CR83","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/intimm\/dxac026","volume":"34","author":"S Tanemura","year":"2022","unstructured":"Tanemura S, Tsujimoto H, Seki N, Kojima S, Miyoshi F, Sugahara K, et al. Role of interferons (IFNs) in the differentiation of T peripheral helper (Tph) cells. Int Immunol. 2022;34(10):519\u201332.","journal-title":"Int Immunol"},{"key":"387_CR84","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3389\/fimmu.2018.00609","volume":"9","author":"M Sebode","year":"2018","unstructured":"Sebode M, Weiler-Normann C, Liwinski T, Schramm C. Autoantibodies in autoimmune liver disease-clinical and diagnostic relevance. Front Immunol. 2018;9:609.","journal-title":"Front Immunol"},{"key":"387_CR85","doi-asserted-by":"crossref","unstructured":"Chen H, Han Z, Fan Y, Chen L, Peng F, Cheng X, et al. CD4+ T-cell subsets in autoimmune hepatitis: a review. Hepatol Commun. 2023;7(10).","DOI":"10.1097\/HC9.0000000000000269"},{"issue":"3","key":"387_CR86","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/liv.12245","volume":"34","author":"L Ma","year":"2014","unstructured":"Ma L, Qin J, Ji H, Zhao P, Jiang Y. Tfh and plasma cells are correlated with hypergammaglobulinaemia in patients with autoimmune hepatitis. Liver Int. 2014;34(3):405\u201315.","journal-title":"Liver Int"},{"issue":"1","key":"387_CR87","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1186\/s40064-016-2512-y","volume":"5","author":"K Abe","year":"2016","unstructured":"Abe K, Takahashi A, Imaizumi H, Hayashi M, Okai K, Kanno Y, et al. Interleukin-21 plays a critical role in the pathogenesis and severity of type I autoimmune hepatitis. Springerplus. 2016;5(1):777.","journal-title":"Springerplus"},{"key":"387_CR88","doi-asserted-by":"crossref","unstructured":"Yang X, Li J, Ren M, Pan X, Liu H, Jiang J, et al. Comprehensive analysis of immune signatures in primary biliary cholangitis and autoimmune hepatitis. J Leukoc Biol. 2024;117(1).","DOI":"10.1093\/jleuko\/qiae085"},{"issue":"4","key":"387_CR89","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00281-022-00950-8","volume":"44","author":"D Ellinghaus","year":"2022","unstructured":"Ellinghaus D. How genetic risk contributes to autoimmune liver disease. Semin Immunopathol. 2022;44(4):397\u2013410.","journal-title":"Semin Immunopathol"},{"issue":"11","key":"387_CR90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112877","volume":"9","author":"LM Stinton","year":"2014","unstructured":"Stinton LM, Bentow C, Mahler M, Norman GL, Eksteen B, Mason AL, et al. PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC). PLoS ONE. 2014;9(11): e112877.","journal-title":"PLoS ONE"},{"issue":"1","key":"387_CR91","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/gutjnl-2016-311739","volume":"66","author":"ST Jendrek","year":"2017","unstructured":"Jendrek ST, Gotthardt D, Nitzsche T, Widmann L, Korf T, Michaels MA, et al. Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis. Gut. 2017;66(1):137\u201344.","journal-title":"Gut"},{"issue":"3","key":"387_CR92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0194166","volume":"13","author":"G Kovacs","year":"2018","unstructured":"Kovacs G, Sipeki N, Suga B, Tornai T, Fechner K, Norman GL, et al. Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patients. PLoS ONE. 2018;13(3): e0194166.","journal-title":"PLoS ONE"},{"key":"387_CR93","doi-asserted-by":"crossref","unstructured":"Wang H, Barrow F, Fredrickson G, Florczak K, Nguyen H, Parthiban P, et al. Dysfunctional T follicular helper cells cause intestinal and hepatic inflammation in NASH. bioRxiv. 2023.","DOI":"10.1101\/2023.06.07.544061"},{"key":"387_CR94","doi-asserted-by":"crossref","unstructured":"Bocharnikov AV, Keegan J, Wacleche VS, Cao Y, Fonseka CY, Wang G, et al. PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21. JCI Insight. 2019;4(20).","DOI":"10.1172\/jci.insight.130062"},{"issue":"7","key":"387_CR95","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1093\/rheumatology\/keac646","volume":"62","author":"Y Shan","year":"2023","unstructured":"Shan Y, Nakayamada S, Nawata A, Yamagata K, Sonomoto K, Tanaka H, et al. TGF-beta3 in differentiation and function of Tph-like cells and its relevance to disease activity in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2023;62(7):2464\u201374.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"387_CR96","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/intimm\/dxad041","volume":"36","author":"H Yoshitomi","year":"2024","unstructured":"Yoshitomi H. Peripheral helper T cells, mavericks of peripheral immune responses. Int Immunol. 2024;36(1):9\u201316.","journal-title":"Int Immunol"},{"issue":"6","key":"387_CR97","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.jhep.2020.05.053","volume":"73","author":"A Renand","year":"2020","unstructured":"Renand A, Cervera-Marzal I, Gil L, Dong C, Garcia A, Kervagoret E, et al. Integrative molecular profiling of autoreactive CD4 T cells in autoimmune hepatitis. J Hepatol. 2020;73(6):1379\u201390.","journal-title":"J Hepatol"},{"key":"387_CR98","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","volume":"29","author":"S Crotty","year":"2011","unstructured":"Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol. 2011;29:621\u201363.","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"387_CR99","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41577-024-00994-x","volume":"24","author":"TS Sumida","year":"2024","unstructured":"Sumida TS, Cheru NT, Hafler DA. The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases. Nat Rev Immunol. 2024;24(7):503\u201317.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"387_CR100","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nri.2016.36","volume":"16","author":"T Tanoue","year":"2016","unstructured":"Tanoue T, Atarashi K, Honda K. Development and maintenance of intestinal regulatory T cells. Nat Rev Immunol. 2016;16(5):295\u2013309.","journal-title":"Nat Rev Immunol"},{"issue":"7129","key":"387_CR101","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nature05543","volume":"445","author":"MA Gavin","year":"2007","unstructured":"Gavin MA, Rasmussen JP, Fontenot JD, Vasta V, Manganiello VC, Beavo JA, et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature. 2007;445(7129):771\u20135.","journal-title":"Nature"},{"issue":"1","key":"387_CR102","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/83707","volume":"27","author":"RS Wildin","year":"2001","unstructured":"Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet. 2001;27(1):18\u201320.","journal-title":"Nat Genet"},{"issue":"9","key":"387_CR103","volume":"16","author":"A Farooq","year":"2024","unstructured":"Farooq A, Trehan S, Singh G, Arora N, Mehta T, Jain P, et al. A comprehensive review of low-dose interleukin-2 (IL-2) therapy for systemic lupus erythematosus: mechanisms, efficacy, and clinical applications. Cureus. 2024;16(9): e68748.","journal-title":"Cureus"},{"issue":"2","key":"387_CR104","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/iub.1349","volume":"67","author":"R Liberal","year":"2015","unstructured":"Liberal R, Grant CR, Longhi MS, Mieli-Vergani G, Vergani D. Regulatory T cells: mechanisms of suppression and impairment in autoimmune liver disease. IUBMB Life. 2015;67(2):88\u201397.","journal-title":"IUBMB Life"},{"issue":"2","key":"387_CR105","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/hep.21498","volume":"45","author":"A Erhardt","year":"2007","unstructured":"Erhardt A, Biburger M, Papadopoulos T, Tiegs G. IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice. Hepatology. 2007;45(2):475\u201385.","journal-title":"Hepatology"},{"issue":"3","key":"387_CR106","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1538\/expanim.22-0171","volume":"72","author":"J Zhu","year":"2023","unstructured":"Zhu J, Chen H, Cui J, Zhang X, Liu G. Oroxylin A inhibited autoimmune hepatitis-induced liver injury and shifted Treg\/Th17 balance to Treg differentiation. Exp Anim. 2023;72(3):367\u201378.","journal-title":"Exp Anim"},{"issue":"1","key":"387_CR107","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jhep.2004.03.008","volume":"41","author":"MS Longhi","year":"2004","unstructured":"Longhi MS, Ma Y, Bogdanos DP, Cheeseman P, Mieli-Vergani G, Vergani D. Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol. 2004;41(1):31\u20137.","journal-title":"J Hepatol"},{"issue":"1","key":"387_CR108","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jaut.2005.05.001","volume":"25","author":"MS Longhi","year":"2005","unstructured":"Longhi MS, Ma Y, Mitry RR, Bogdanos DP, Heneghan M, Cheeseman P, et al. Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. J Autoimmun. 2005;25(1):63\u201371.","journal-title":"J Autoimmun"},{"issue":"3","key":"387_CR109","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/hep.23792","volume":"52","author":"S Ferri","year":"2010","unstructured":"Ferri S, Longhi MS, De Molo C, Lalanne C, Muratori P, Granito A, et al. A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology. 2010;52(3):999\u20131007.","journal-title":"Hepatology"},{"issue":"2","key":"387_CR110","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/hep.25682","volume":"56","author":"R Liberal","year":"2012","unstructured":"Liberal R, Grant CR, Holder BS, Ma Y, Mieli-Vergani G, Vergani D, et al. The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9\/tim-3 pathway. Hepatology. 2012;56(2):677\u201386.","journal-title":"Hepatology"},{"key":"387_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102629","volume":"119","author":"E McEachern","year":"2021","unstructured":"McEachern E, Carroll AM, Fribourg M, Schiano TD, Hartzell S, Bin S, et al. Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis. J Autoimmun. 2021;119: 102629.","journal-title":"J Autoimmun"},{"issue":"2","key":"387_CR112","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1365-2249.2009.03898.x","volume":"156","author":"G Rong","year":"2009","unstructured":"Rong G, Zhou Y, Xiong Y, Zhou L, Geng H, Jiang T, et al. Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population. Clin Exp Immunol. 2009;156(2):217\u201325.","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"387_CR113","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/hep.21123","volume":"43","author":"RY Lan","year":"2006","unstructured":"Lan RY, Cheng C, Lian ZX, Tsuneyama K, Yang GX, Moritoki Y, et al. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology. 2006;43(4):729\u201337.","journal-title":"Hepatology"},{"issue":"5","key":"387_CR114","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.jhep.2013.12.027","volume":"60","author":"M Sebode","year":"2014","unstructured":"Sebode M, Peiseler M, Franke B, Schwinge D, Schoknecht T, Wortmann F, et al. Reduced FOXP3(+) regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms. J Hepatol. 2014;60(5):1010\u20136.","journal-title":"J Hepatol"},{"issue":"10","key":"387_CR115","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1136\/jcp.2006.044776","volume":"60","author":"M Sasaki","year":"2007","unstructured":"Sasaki M, Ikeda H, Sawada S, Sato Y, Nakanuma Y. Naturally-occurring regulatory T cells are increased in inflamed portal tracts with cholangiopathy in primary biliary cirrhosis. J Clin Pathol. 2007;60(10):1102\u20137.","journal-title":"J Clin Pathol"},{"issue":"6","key":"387_CR116","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/cmi.2010.40","volume":"7","author":"D Wang","year":"2010","unstructured":"Wang D, Zhang H, Liang J, Gu Z, Zhou Q, Fan X, et al. CD4+ CD25+ but not CD4+ Foxp3+ T cells as a regulatory subset in primary biliary cirrhosis. Cell Mol Immunol. 2010;7(6):485\u201390.","journal-title":"Cell Mol Immunol"},{"key":"387_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113613","volume":"144","author":"F An","year":"2025","unstructured":"An F, Jia X, Shi Y, Xiao X, Yang F, Su J, et al. The ultimate microbial composition for correcting Th17\/Treg cell imbalance and lipid metabolism disorders in osteoporosis. Int Immunopharmacol. 2025;144: 113613.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"387_CR118","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12865-017-0215-y","volume":"18","author":"B He","year":"2017","unstructured":"He B, Wu L, Xie W, Shao Y, Jiang J, Zhao Z, et al. The imbalance of Th17\/Treg cells is involved in the progression of nonalcoholic fatty liver disease in mice. BMC Immunol. 2017;18(1):33.","journal-title":"BMC Immunol"},{"issue":"1","key":"387_CR119","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1038\/s41598-021-84674-z","volume":"11","author":"V Cairoli","year":"2021","unstructured":"Cairoli V, De Matteo E, Rios D, Lezama C, Galoppo M, Casciato P, et al. Hepatic lymphocytes involved in the pathogenesis of pediatric and adult non-alcoholic fatty liver disease. Sci Rep. 2021;11(1):5129.","journal-title":"Sci Rep"},{"issue":"7","key":"387_CR120","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/j.1600-0463.2011.02746.x","volume":"119","author":"C Soderberg","year":"2011","unstructured":"Soderberg C, Marmur J, Eckes K, Glaumann H, Sallberg M, Frelin L, et al. Microvesicular fat, inter cellular adhesion molecule-1 and regulatory T-lymphocytes are of importance for the inflammatory process in livers with non-alcoholic steatohepatitis. APMIS. 2011;119(7):412\u201320.","journal-title":"APMIS"},{"key":"387_CR121","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.12659\/MSM.899725","volume":"23","author":"X Zhang","year":"2017","unstructured":"Zhang X, Lou J, Bai L, Chen Y, Zheng S, Duan Z. Immune regulation of intrahepatic regulatory T cells in fibrotic livers of mice. Med Sci Monit. 2017;23:1009\u201316.","journal-title":"Med Sci Monit"},{"key":"387_CR122","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.584048","volume":"11","author":"Y Ikeno","year":"2020","unstructured":"Ikeno Y, Ohara D, Takeuchi Y, Watanabe H, Kondoh G, Taura K, et al. Foxp3+ Regulatory T cells inhibit CCl(4)-induced liver inflammation and fibrosis by regulating tissue cellular immunity. Front Immunol. 2020;11: 584048.","journal-title":"Front Immunol"},{"issue":"9","key":"387_CR123","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41577-021-00519-w","volume":"21","author":"AR Munoz-Rojas","year":"2021","unstructured":"Munoz-Rojas AR, Mathis D. Tissue regulatory T cells: regulatory chameleons. Nat Rev Immunol. 2021;21(9):597\u2013611.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"387_CR124","doi-asserted-by":"publisher","first-page":"G313","DOI":"10.1152\/ajpgi.00097.2016","volume":"311","author":"G Noel","year":"2016","unstructured":"Noel G, Arshad MI, Filliol A, Genet V, Rauch M, Lucas-Clerc C, et al. Ablation of interaction between IL-33 and ST2+ regulatory T cells increases immune cell-mediated hepatitis and activated NK cell liver infiltration. Am J Physiol Gastrointest Liver Physiol. 2016;311(2):G313\u201323.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"8","key":"387_CR125","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/ni.1770","volume":"10","author":"S Trifari","year":"2009","unstructured":"Trifari S, Kaplan CD, Tran EH, Crellin NK, Spits H. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol. 2009;10(8):864\u201371.","journal-title":"Nat Immunol"},{"issue":"5","key":"387_CR126","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.celrep.2017.10.022","volume":"21","author":"N Nakamoto","year":"2017","unstructured":"Nakamoto N, Amiya T, Aoki R, Taniki N, Koda Y, Miyamoto K, et al. Commensal Lactobacillus controls immune tolerance during acute liver injury in mice. Cell Rep. 2017;21(5):1215\u201326.","journal-title":"Cell Rep"},{"issue":"4","key":"387_CR127","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.immuni.2007.07.023","volume":"27","author":"LA Zenewicz","year":"2007","unstructured":"Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Karow M, Flavell RA. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity. 2007;27(4):647\u201359.","journal-title":"Immunity"},{"issue":"6","key":"387_CR128","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.4049\/jimmunol.177.6.3635","volume":"177","author":"H Chang","year":"2006","unstructured":"Chang H, Hanawa H, Liu H, Yoshida T, Hayashi M, Watanabe R, et al. Hydrodynamic-based delivery of an interleukin-22-Ig fusion gene ameliorates experimental autoimmune myocarditis in rats. J Immunol. 2006;177(6):3635\u201343.","journal-title":"J Immunol"},{"issue":"4","key":"387_CR129","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062853","volume":"8","author":"A Matsumoto","year":"2013","unstructured":"Matsumoto A, Kanai T, Mikami Y, Chu PS, Nakamoto N, Ebinuma H, et al. IL-22-producing RORgammat-dependent innate lymphoid cells play a novel protective role in murine acute hepatitis. PLoS ONE. 2013;8(4): e62853.","journal-title":"PLoS ONE"},{"issue":"7","key":"387_CR130","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.it.2024.05.008","volume":"45","author":"AY Yang","year":"2024","unstructured":"Yang AY, Wistuba-Hamprecht K, Greten TF, Ruf B. Innate-like T cells in liver disease. Trends Immunol. 2024;45(7):535\u201348.","journal-title":"Trends Immunol"},{"key":"387_CR131","doi-asserted-by":"publisher","first-page":"1114605","DOI":"10.3389\/fimmu.2023.1114605","volume":"14","author":"M Papanastasatou","year":"2023","unstructured":"Papanastasatou M, Verykokakis M. Innate-like T lymphocytes in chronic liver disease. Front Immunol. 2023;14:1114605.","journal-title":"Front Immunol"},{"issue":"12","key":"387_CR132","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/s41577-020-0345-y","volume":"20","author":"DG Pellicci","year":"2020","unstructured":"Pellicci DG, Koay HF, Berzins SP. Thymic development of unconventional T cells: how NKT cells, MAIT cells and gammadelta T cells emerge. Nat Rev Immunol. 2020;20(12):756\u201370.","journal-title":"Nat Rev Immunol"},{"key":"387_CR133","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3389\/fimmu.2015.00255","volume":"6","author":"D Slauenwhite","year":"2015","unstructured":"Slauenwhite D, Johnston B. Regulation of NKT cell localization in homeostasis and infection. Front Immunol. 2015;6:255.","journal-title":"Front Immunol"},{"key":"387_CR134","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1034\/j.1600-0528.2002.017416.x","volume":"174","author":"DG Doherty","year":"2000","unstructured":"Doherty DG, O\u2019Farrelly C. Innate and adaptive lymphoid cells in the human liver. Immunol Rev. 2000;174:5\u201320.","journal-title":"Immunol Rev"},{"issue":"11","key":"387_CR135","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/hep4.1584","volume":"4","author":"L Gao","year":"2020","unstructured":"Gao L, Li B, Wang J, Shen D, Yang M, Sun R, et al. Activation of liver X receptor alpha sensitizes mice to T-cell mediated hepatitis. Hepatol Commun. 2020;4(11):1664\u201379.","journal-title":"Hepatol Commun"},{"issue":"3","key":"387_CR136","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/hep.24113","volume":"53","author":"SJ Wu","year":"2011","unstructured":"Wu SJ, Yang YH, Tsuneyama K, Leung PS, Illarionov P, Gershwin ME, et al. Innate immunity and primary biliary cirrhosis: activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis. Hepatology. 2011;53(3):915\u201325.","journal-title":"Hepatology"},{"issue":"6928","key":"387_CR137","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nature01433","volume":"422","author":"E Treiner","year":"2003","unstructured":"Treiner E, Duban L, Bahram S, Radosavljevic M, Wanner V, Tilloy F, et al. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature. 2003;422(6928):164\u20139.","journal-title":"Nature"},{"issue":"7426","key":"387_CR138","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nature11605","volume":"491","author":"L Kjer-Nielsen","year":"2012","unstructured":"Kjer-Nielsen L, Patel O, Corbett AJ, Le Nours J, Meehan B, Liu L, et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature. 2012;491(7426):717\u201323.","journal-title":"Nature"},{"issue":"4","key":"387_CR139","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1182\/blood-2010-08-303339","volume":"117","author":"M Dusseaux","year":"2011","unstructured":"Dusseaux M, Martin E, Serriari N, Peguillet I, Premel V, Louis D, et al. Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood. 2011;117(4):1250\u20139.","journal-title":"Blood"},{"issue":"7","key":"387_CR140","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1084\/jem.20142110","volume":"212","author":"A Rahimpour","year":"2015","unstructured":"Rahimpour A, Koay HF, Enders A, Clanchy R, Eckle SB, Meehan B, et al. Identification of phenotypically and functionally heterogeneous mouse mucosal-associated invariant T cells using MR1 tetramers. J Exp Med. 2015;212(7):1095\u2013108.","journal-title":"J Exp Med"},{"issue":"8","key":"387_CR141","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/hep4.1202","volume":"2","author":"A Renand","year":"2018","unstructured":"Renand A, Habes S, Mosnier JF, Auble H, Judor JP, Vince N, et al. Immune alterations in patients with type 1 autoimmune hepatitis persist upon standard immunosuppressive treatment. Hepatol Commun. 2018;2(8):968\u201381.","journal-title":"Hepatol Commun"},{"key":"387_CR142","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jaut.2018.01.007","volume":"90","author":"X Jiang","year":"2018","unstructured":"Jiang X, Lian M, Li Y, Zhang W, Wang Q, Wei Y, et al. The immunobiology of mucosal-associated invariant T cell (MAIT) function in primary biliary cholangitis: Regulation by cholic acid-induced Interleukin-7. J Autoimmun. 2018;90:64\u201375.","journal-title":"J Autoimmun"},{"issue":"1","key":"387_CR143","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1038\/s41467-023-37453-5","volume":"14","author":"M Mabire","year":"2023","unstructured":"Mabire M, Hegde P, Hammoutene A, Wan J, Caer C, Sayegh RA, et al. MAIT cell inhibition promotes liver fibrosis regression via macrophage phenotype reprogramming. Nat Commun. 2023;14(1):1830.","journal-title":"Nat Commun"},{"issue":"2","key":"387_CR144","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/hep.26697","volume":"59","author":"L Hammerich","year":"2014","unstructured":"Hammerich L, Bangen JM, Govaere O, Zimmermann HW, Gassler N, Huss S, et al. Chemokine receptor CCR6-dependent accumulation of gammadelta T cells in injured liver restricts hepatic inflammation and fibrosis. Hepatology. 2014;59(2):630\u201342.","journal-title":"Hepatology"},{"key":"387_CR145","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3389\/fimmu.2019.00477","volume":"10","author":"M Liu","year":"2019","unstructured":"Liu M, Hu Y, Yuan Y, Tian Z, Zhang C. gammadeltaT cells suppress liver fibrosis via strong cytolysis and enhanced NK cell-mediated cytotoxicity against hepatic stellate cells. Front Immunol. 2019;10:477.","journal-title":"Front Immunol"},{"key":"387_CR146","doi-asserted-by":"crossref","unstructured":"Nowak K, Lupina K, Romac A, Kalisz A, Ilkiewicz L, Janczura J. Therapeutic potential of GLP-1 receptor agonists in metabolic associated steatotic liver disease. Ann Pharmacother. 2025:10600280251322002.","DOI":"10.1177\/10600280251322002"},{"issue":"1","key":"387_CR147","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41575-024-00991-4","volume":"22","author":"RA Sinha","year":"2025","unstructured":"Sinha RA, Bruinstroop E, Yen PM. Actions of thyroid hormones and thyromimetics on the liver. Nat Rev Gastroenterol Hepatol. 2025;22(1):9\u201322.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"387_CR148","doi-asserted-by":"crossref","unstructured":"Cheraghpour M, Hatami B, Singal AG. Lifestyle and pharmacologic approaches to prevention of metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2025.","DOI":"10.1016\/j.cgh.2024.09.041"},{"key":"387_CR149","doi-asserted-by":"crossref","unstructured":"Barb D, Kalavalapalli S, Leiva EG, Bril F, Huot-Marchand P, Dzen L, et al. Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD. J Hepatol. 2025.","DOI":"10.1016\/j.jhep.2024.12.045"},{"issue":"3","key":"387_CR150","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1159\/000322693","volume":"4","author":"E Barth","year":"2010","unstructured":"Barth E, Clawson J. A case of autoimmune hepatitis treated with rituximab. Case Rep Gastroenterol. 2010;4(3):502\u20139.","journal-title":"Case Rep Gastroenterol"},{"issue":"2","key":"387_CR151","doi-asserted-by":"publisher","first-page":"e526","DOI":"10.1542\/peds.2011-1900","volume":"132","author":"D D'Agostino","year":"2013","unstructured":"D\u2019Agostino D, Costaguta A, Alvarez F. Successful treatment of refractory autoimmune hepatitis with rituximab. Pediatrics. 2013;132(2):e526\u201330.","journal-title":"Pediatrics"},{"issue":"6","key":"387_CR152","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jhepr.2019.10.005","volume":"1","author":"NN Than","year":"2019","unstructured":"Than NN, Hodson J, Schmidt-Martin D, Taubert R, Wawman RE, Botter M, et al. Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group. JHEP Rep. 2019;1(6):437\u201345.","journal-title":"JHEP Rep"},{"issue":"8","key":"387_CR153","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1016\/j.cgh.2023.04.004","volume":"21","author":"DN Assis","year":"2023","unstructured":"Assis DN, Bowlus CL. Recent advances in the management of primary sclerosing cholangitis. Clin Gastroenterol Hepatol. 2023;21(8):2065\u201375.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"387_CR154","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1038\/s41467-023-39029-9","volume":"14","author":"M Ichikawa","year":"2023","unstructured":"Ichikawa M, Nakamoto N, Kredo-Russo S, Weinstock E, Weiner IN, Khabra E, et al. Bacteriophage therapy against pathological Klebsiella pneumoniae ameliorates the course of primary sclerosing cholangitis. Nat Commun. 2023;14(1):3261.","journal-title":"Nat Commun"},{"key":"387_CR155","doi-asserted-by":"crossref","unstructured":"Gupta B, Rai RP, Pal PB, Rossmiller D, Chaudhary S, Chiaro A, et al. Selective targeting of alpha(4)beta(7)\/MAdCAM-1 axis suppresses fibrosis progression by reducing proinflammatory T cell recruitment to the liver. Cells. 2024;13(9).","DOI":"10.3390\/cells13090756"},{"issue":"7814","key":"387_CR156","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","volume":"583","author":"C Amor","year":"2020","unstructured":"Amor C, Feucht J, Leibold J, Ho YJ, Zhu C, Alonso-Curbelo D, et al. Senolytic CAR T cells reverse senescence-associated pathologies. Nature. 2020;583(7814):127\u201332.","journal-title":"Nature"},{"issue":"1","key":"387_CR157","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1136\/ard-2024-226142","volume":"84","author":"C Tur","year":"2025","unstructured":"Tur C, Eckstein M, Velden J, Rauber S, Bergmann C, Auth J, et al. CD19-CAR T-cell therapy induces deep tissue depletion of B cells. Ann Rheum Dis. 2025;84(1):106\u201314.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"387_CR158","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41584-024-01210-9","volume":"21","author":"M Stockfelt","year":"2025","unstructured":"Stockfelt M, Teng YKO, Vital EM. Opportunities and limitations of B cell depletion approaches in SLE. Nat Rev Rheumatol. 2025;21(2):111\u201326.","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"387_CR159","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.jcmgh.2023.08.002","volume":"16","author":"S Umeda","year":"2023","unstructured":"Umeda S, Sujino T, Miyamoto K, Yoshimatsu Y, Harada Y, Nishiyama K, et al. D-amino acids ameliorate experimental colitis and cholangitis by inhibiting growth of proteobacteria: potential therapeutic role in inflammatory bowel disease. Cell Mol Gastroenterol Hepatol. 2023;16(6):1011\u201331.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"387_CR160","doi-asserted-by":"crossref","unstructured":"Quraishi MN, Cheesbrough J, Rimmer P, Mullish BH, Sharma N, Efstathiou E, et al. Open label vancomycin in primary sclerosing cholangitis-inflammatory bowel disease: improved colonic disease activity and associations with changes in host-microbiome-metabolomic signatures. J Crohns Colitis. 2025;19(2).","DOI":"10.1093\/ecco-jcc\/jjae189"}],"container-title":["Inflammation and Regeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41232-025-00387-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41232-025-00387-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41232-025-00387-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T11:04:21Z","timestamp":1751627061000},"score":1,"resource":{"primary":{"URL":"https:\/\/inflammregen.biomedcentral.com\/articles\/10.1186\/s41232-025-00387-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":160,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["387"],"URL":"https:\/\/doi.org\/10.1186\/s41232-025-00387-0","relation":{},"ISSN":["1880-8190"],"issn-type":[{"value":"1880-8190","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]},"assertion":[{"value":"21 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"YK is an employee of Mitsubishi Tanabe Pharma Corporation. Other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}